Marinol and Etoposide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Marinol (dronabinol) and Etoposide (etoposide). Common drug interactions include asthenia among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Marinol and Etoposide. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Marinol?

Marinol has active ingredients of dronabinol. It is often used in pain. eHealthMe is studying from 4,963 Marinol users. Check the latest studies of Marinol.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

On Jul, 12, 2026

17 people who take Marinol and Etoposide together, and have interactions are studied.

Marinol and Etoposide drug interactions.

What are the common drug interactions of Marinol and Etoposide, by gender? *:

female:

Asthenia (weakness)
Vomiting
Dehydration (dryness resulting from the removal of water)
Febrile neutropenia (fever with reduced white blood cells)
Mucosal inflammation (infection of mucous membrane)
Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)

male:

Pyrexia (fever)
Thrombocytopenia (decrease of platelets in blood)
Brain neoplasm malignant (brain cancer tumour)
C-reactive protein increased
Chills (felling of cold)
Colitis (inflammation of colon)
Death
Dehydration (dryness resulting from the removal of water)
Disease progression
Disease recurrence

What are the common drug interactions of Marinol and Etoposide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Asthenia (weakness)
Neutropenia (an abnormally low number of neutrophils)
Pyrexia (fever)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Brain neoplasm malignant (brain cancer tumour)
Cellulitis (infection under the skin)
Chest pain
Dehydration (dryness resulting from the removal of water)
Haemoglobin decreased
Hypersensitivity

20-29:

Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Constipation
Dehydration (dryness resulting from the removal of water)
Vomiting

30-39:

n/a

40-49:

Pyrexia (fever)
Thrombocytopenia (decrease of platelets in blood)
Multiple myeloma (cancer of the plasma cells)
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Pulmonary haemorrhage (acute bleeding from the lung)
Abdominal pain
Confusional state
Diarrhoea
Septic shock (shock due to blood infection)
Blood culture positive

50-59:

Febrile neutropenia (fever with reduced white blood cells)
Mucosal inflammation (infection of mucous membrane)
Cytomegalovirus infection
Cytomegalovirus viraemia (cytomegalo virus in blood stream)
Death
Delusion (a false belief or opinion)
Diarrhoea
Heart rate increased
Hypotension (abnormally low blood pressure)
Injection site erythema (redness at injection site)

60+:

n/a

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 29.41%
Nausea (feeling of having an urge to vomit): 3 people, 17.65%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 11.76%
Brain Neoplasm Malignant (brain cancer tumour): 2 people, 11.76%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 5.88%
Insomnia (sleeplessness): 1 person, 5.88%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 5.88%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 5.88%
Bone Marrow Conditioning Regimen: 1 person, 5.88%
Cough: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Marinol and Etoposide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously